Spots Global Cancer Trial Database for Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer
Official Title: Phase Ⅱa,Open Label,Multicenter Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer
Study ID: NCT01305967
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine efficacy of SB injection in Non Small Cell Lung Cancer.
Detailed Description: All eligible patients will receive SB injection therapy for 4 cycles (14\~21 days for each cycle). SB injection treatment could be continue after completion of therapy cycles until 6th cycle. It depends on the investigator's decision and patient's will. Efficacy will be evaluated every two cycles.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Keimyung University Dongsan Hospital, Daegu, Jung-gu, Korea, Republic of
Kyungpook University Hospital, Deagu, Jung-gu, Korea, Republic of
Sam Anyang Medical Center, Anyang, Man-an-gu, Korea, Republic of
Contact Details
Name: Jae-yong Park, Professor
Affiliation: Kyungpook University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Seung-beom Han, Professor
Affiliation: Keimyung University Dongsan Medical Center
Role: PRINCIPAL_INVESTIGATOR
Name: Chae-young Lee, Medical Doctor
Affiliation: Anyang Sam Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
